This inventor holds 1 USPTO granted patent. Top assignees: Imperial Chemical Industries Limited, National Research Development Corporation. Active years: 1984.
Company Filing History:
1 out of 3,840 
1 out of 1,200 
Years Active: 1984
Title: John S Lowe: Innovator in Pharmaceutical Compositions
Introduction
John S Lowe is a notable inventor based in Wilmslow, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative treatments for inflammation.
Latest Patents
John S Lowe holds 1 patent for his work on pharmaceutical liposome compositions. His patent focuses on compositions containing an anti-inflammatory steroid derivative, such as cortisol 21-hexadecanoate. The method described involves treating inflammation at a site with an enclosed cavity, which includes the treatment of rheumatic diseases by injecting the pharmaceutical liposome composition into the affected cavity. Additionally, he has specified new steroid derivatives, including fluocinolone acetamide 21-hexadecanoate.
Career Highlights
Throughout his career, John S Lowe has worked with prominent organizations, including Imperial Chemical Industries Limited and the National Research Development Corporation. His work has contributed to advancements in pharmaceutical science and treatment methodologies.
Collaborations
John S Lowe has collaborated with notable individuals in his field, including John T Dingle and John L Gordon. These collaborations have likely enriched his research and development efforts.
Conclusion
John S Lowe's innovative work in pharmaceutical compositions demonstrates his commitment to advancing medical treatments. His contributions have the potential to significantly impact the management of inflammatory conditions.